Matthew McClorey

Matthew McClorey is President of CritiTech. He leads the company’s strategy, overall direction and execution. He manages key partnerships, leads capital formation operations and guides the leadership team to drive financial and operational performance. He also serves on the CritiTech Board.

Before joining CritiTech in 2012, Matthew spent over 10 years in a variety of executive leadership, investment management and operations roles with early stage life science companies. As President of the Lawrence Regional Technology Center and Bioscience and Technology Business Center, he led their growth into one of the largest and most successful business incubators in the Midwest. During his tenure, incubator clients raised over $190M. Life sciences clients included Deciphera Pharmaceuticals, Proteon Therapeutics, Innara Health, CritiTech and Validic. Previously, Matthew was a Senior Consultant with Deloitte Consulting, working with several Fortune 100 companies. He currently serves on the Boards of NanOlogy, LLC, an oncology drug development company, Truity Credit Union and Benedictine College.

Matthew earned his M.B.A. and Juris Doctorate at the University Kansas, and holds a B.A. in Business Administration from Benedictine College. He loves traveling and playing sports with his family, coaching basketball, running, mountain-biking, bass-fishing, and is a die-hard KU, Kansas City and Detroit sports fan.